Reprogramming Autophagy to Strengthen Antitumour Immunity: Advances in Immunotherapeutic Strategies

Area of Science:

• Cellular Biology
• Immunology
• Oncology

Background:

• Autophagy is a fundamental cellular process vital for maintaining homeostasis.
• Autophagy plays a dual role in cancer, contributing to immune evasion and treatment resistance, which hinders cancer immunotherapy.
• Targeting autophagy presents a potential strategy to improve therapeutic outcomes in cancer treatment.

Purpose of the Study:

• To explore the potential of modulating autophagy to enhance cancer immunotherapy.
• To understand the molecular mechanisms by which autophagy influences immune activity and treatment response within the tumor microenvironment.
• To identify new therapeutic opportunities by refining the understanding of autophagy's role in cancer.

Main Methods:

• Review and analysis of current research on autophagy's role in the tumor immune microenvironment.
• Exploration of molecular pathways linking autophagy to immune evasion and treatment resistance.
• Discussion of potential therapeutic strategies involving selective autophagy targeting and combination approaches.

Main Results:

• Autophagy's complex role in cancer necessitates targeted modulation for therapeutic benefit.
• Understanding autophagy's impact on immune cells and tumor cells is key to overcoming resistance.
• Selective targeting of specific autophagy pathways shows promise in enhancing immunotherapy efficacy.

Conclusions:

• Modulating autophagy holds significant potential for improving cancer immunotherapy outcomes.
• Further research into compartment-specific autophagy control and combination therapies is needed.
• Integrating insights from immuno-oncology and metabolic regulation may accelerate clinical translation of autophagy-based therapies.